🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 21 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/01/1988 | 8,22 | 8,43 | 8,22 | 8,40 | +0,63% | 2,50% | 9.356.544 |
| 08/01/1988 | 8,81 | 8,91 | 8,26 | 8,35 | -5,55% | 7,29% | 10.309.176 |
| 07/01/1988 | 8,67 | 8,87 | 8,64 | 8,84 | +1,37% | 2,68% | 7.343.755 |
| 06/01/1988 | 8,85 | 8,88 | 8,72 | 8,72 | -1,64% | 1,80% | 7.549.373 |
| 05/01/1988 | 9,01 | 9,04 | 8,84 | 8,87 | +1,75% | 2,21% | 11.088.259 |
| 04/01/1988 | 8,48 | 8,75 | 8,48 | 8,71 | +3,71% | 3,12% | 10.086.581 |
| 31/12/1987 | 8,38 | 8,42 | 8,35 | 8,40 | -0,24% | 0,87% | 5.280.034 |
| 30/12/1987 | 8,28 | 8,42 | 8,28 | 8,42 | +1,92% | 1,68% | 5.508.288 |
| 29/12/1987 | 8,28 | 8,30 | 8,18 | 8,26 | -0,24% | 1,44% | 4.040.669 |
| 28/12/1987 | 8,38 | 8,38 | 8,18 | 8,28 | -2,65% | 2,37% | 5.576.198 |
| 24/12/1987 | 8,57 | 8,57 | 8,48 | 8,51 | -0,31% | 1,00% | 1.959.970 |
| 23/12/1987 | 8,53 | 8,56 | 8,44 | 8,53 | +0,47% | 1,40% | 6.017.616 |
| 22/12/1987 | 8,59 | 8,59 | 8,42 | 8,50 | -1,08% | 2,01% | 5.623.358 |
| 21/12/1987 | 8,51 | 8,61 | 8,50 | 8,59 | +0,62% | 1,40% | 6.611.832 |
| 18/12/1987 | 8,36 | 8,57 | 8,27 | 8,53 | +2,38% | 3,57% | 16.121.174 |
| 17/12/1987 | 8,56 | 8,57 | 8,30 | 8,34 | -2,33% | 3,17% | 8.805.715 |
| 16/12/1987 | 8,38 | 8,53 | 8,11 | 8,53 | +1,42% | 5,06% | 13.721.674 |
| 15/12/1987 | 8,58 | 8,59 | 8,38 | 8,42 | -1,24% | 2,47% | 10.758.139 |
| 14/12/1987 | 8,35 | 8,52 | 8,34 | 8,52 | +2,39% | 2,22% | 9.343.339 |
| 11/12/1987 | 8,40 | 8,51 | 8,32 | 8,32 | -1,26% | 2,21% | 7.200.389 |
| 10/12/1987 | 8,38 | 8,75 | 8,32 | 8,43 | -1,39% | 5,06% | 12.627.562 |
| 09/12/1987 | 8,36 | 8,69 | 8,36 | 8,55 | +1,74% | 4,04% | 10.435.565 |
| 08/12/1987 | 8,34 | 8,40 | 8,10 | 8,40 | +0,32% | 3,65% | 10.552.522 |
| 07/12/1987 | 8,22 | 8,38 | 8,19 | 8,38 | +2,93% | 2,26% | 9.997.920 |
| 04/12/1987 | 8,38 | 8,46 | 8,11 | 8,14 | -4,06% | 4,11% | 15.255.317 |
| 03/12/1987 | 9,03 | 9,05 | 8,48 | 8,48 | -5,81% | 6,31% | 11.361.787 |
| 02/12/1987 | 8,96 | 9,06 | 8,91 | 9,01 | +0,82% | 1,77% | 7.417.325 |
| 01/12/1987 | 9,09 | 9,09 | 8,93 | 8,93 | -0,88% | 1,75% | 10.363.882 |
| 30/11/1987 | 9,08 | 9,22 | 8,92 | 9,01 | -3,13% | 3,36% | 13.431.168 |
| 27/11/1987 | 9,42 | 9,45 | 9,30 | 9,30 | -1,82% | 1,55% | 3.063.514 |